The heart of CordenPharma’s API manufacturing history and capacity remains our Small Molecules Platform. Our integrated network of facilities brings a combined 200+ years of manufacturing experience to bear on your project, with over 1,200,000 Liters of volumetric capacity ranging from 20 L to 28,000 L reactors of various materials of construction. With our commercial track record we develop and advance your small molecule projects through clinical trials to commercial launch. A strong financial background formed from existing commercial projects means you can rely on the stability of our small molecule CDMO partnership to support you through clinical trials to commercial launch.
Our extensive network of facilities in Liestal (CH), Chenôve (FR), Colorado (US) and Bergamo (IT) allows for services that enable your asset to travel smoothly from preclinical supply to a successful commercial launch with phase-appropriate development for effective management of financial budgets.
Beyond the Small Molecules Platform, your benefit expands to the seamless tech transfer of your project within our facility network for the production of Drug Products & Packaging Services. The Injectables Platform provides Aseptic & Terminal Sterilization Fill & Finish in Pre-Filled Syringes (PFS), ampoules, liquid & lyophilized vials, as well as combination device products, packaging & labeling, and clinical trial kit management.